Edemera Global Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 169.32%
- Profit Growth -328.21%
- Ebitda -1220.37%
- Net Worth -1266.54%
- Total Assets 3319.19%
About Edemera Global
Edemera Global Private Limited (EGPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 August 2020 (Four years and six months 3 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52100TG2020PTC142376
-
Company No.
142376
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Aug 2020
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Edemera Global?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balaraju Edem
|
Director | 01-Aug-2020 | Current |
|
Lakshmi Pappu
|
Director | 01-Aug-2020 | Current |
|
Sajendra Linga
|
Director | 01-Aug-2020 | Current |
Financial Performance of Edemera Global.
Edemera Global Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 169.32% increase. The company also saw a substantial fall in profitability, with a 328.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1266.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Edemera Global?
Unlock access to Edemera Global's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Timetech Lifesciences LimitedBalaraju Edem and Sajendra Linga are mutual person
-
Yashod Private LimitedSajendra Linga is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Edemera Global?
Unlock and access historical data on people associated with Edemera Global, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Edemera Global, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edemera Global's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.